BI-Sifrol Tablets [pramipexole] Special Drug Use Surveillance (Survey on the Safety and Efficacy in Parkinson's Disease Patients With Depressive Symptoms).
Phase of Trial: Phase IV
Latest Information Update: 23 Sep 2014
At a glance
- Drugs Pramipexole (Primary)
- Indications Parkinson's disease
- Focus Adverse reactions
- Sponsors Boehringer Ingelheim
- 04 Nov 2009 Actual patient number (1087) added as reported by ClinicalTrials.gov.
- 04 Nov 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 24 Jul 2009 Planned end date changed from 1 Jun 2009 to 1 Sep 2009 as reported by ClinicalTrials.gov.